Table II.
Independent prognostic value of NFYA in diffuse and intestinal gastric cancer.
| Variable | Diffuse gastric cancer
|
Intestinal gastric cancer
|
||
|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| NFYA (negative vs. positive) | 0.560 (0.349, 0.900) | 0.017 | Variable eliminated | |
| Sex (male vs. female) | Variable eliminated | 2.088 (1.040, 4.191) | 0.038 | |
| Age | 1.029 (1.009, 1.049) | 0.005 | 1.059 (1.023, 1.096) | 0.001 |
| Stage | ||||
| Stage III vs. I/II | 2.286 (1.086, 4.812) | 0.029 | Variable eliminated | |
| Stage IV vs. I/II | 13.002 (6.213, 27.210) | <0.001 | Variable eliminated | |
| T (3 and 4 vs. 1 and 2) | Variable eliminated | 3.365 (1.956, 5.788) | <0.001 | |
| N (positive vs. negative) | Variable eliminated | 1.483 (1.093, 2.012) | 0.011 | |
| M (positive vs. negative) | Variable eliminated | 2.520 (0.851, 7.460) | 0.095 | |
| Overall Cox model | <0.001 | <0.001 | ||
Variable eliminated, variables that were not statistically significant were eliminated in the model. Overall Cox model, the model including all variables that were not eliminated. CI, confidence interval; HR, hazard rate; NFYA, nuclear transcription factor Y subunit α.